CNS Pharmaceuticals Company Presentation

CNS pharmaceuticals 8 BERUBICIN IS THE FIRST ANTHRACYCLINE TO CROSS THE BLOOD-BRAIN BARRIER IN ADULTS AND REACH TUMOR CELLS IN PATIENTS WITH BRAIN CANCER. • Anthracyclines are among the most effective anti-cancer treatments ever developed. • According to academic literature, anthracyclines have demonstrated anti-tumor activity in a wide range of cancers including breast, stomach, uterine, ovarian, bladder, lung and hematological malignancies. • Where effective, anthracyclines are generally considered to be preferred first-line therapeutics. • Anthracyclines have never been shown to cross the blood-brain barrier in the adult brain and affect deadly brain cancers, until now. About Anthracyclines.